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Abstract
C—H functionalization is an attractive strategy to construct and diversify molecules. Heme 
proteins, predominantly cytochromes P450, are responsible for an array of C—H oxidations in 
biology. Recent work has coupled concepts from synthetic chemistry, computation, and natural 
product biosynthesis to engineer heme protein systems to deliver products with tailored oxidation 
patterns. Heme protein catalysis has been shown to go well beyond these native reactions and now 
accesses new-to-nature C—H transformations, including C—N and C—C bond forming 
processes. Emerging work with these systems moves us along the ambitious path of building 
complexity from the ubiquitous C—H bond.
Graphical Abstract
Introduction
Selective replacement of the ubiquitous carbon—hydrogen (C—H) bond with a carbon—
heteroatom or a carbon—carbon bond is an outstanding synthetic chemistry challenge to 
which engineered enzymes are starting to make important contributions. Collectively termed 
C—H functionalization, this set of reactions has the immense potential to change the logic 
of chemical synthesis [1, 2]. Though its development in synthetic chemistry has mainly been 
realized in the last few decades, nature has utilized a C—H functionalization approach to 
diversify molecules for eons. Most biological C—H functionalization reactions are catalyzed 
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by cytochromes P450, a superfamily of heme-thiolate monooxygenases [3]. Inspired by the 
heme cofactor, early work with small-molecule transition metal catalysts for C—H 
hydroxylation employed the porphyrin scaffold [4]. It has since been demonstrated that 
porphyrin is a versatile scaffold for diverse C—H functionalization reactions (Figure 1a) [5, 
6].
We believe that nature’s heme proteins have great potential for C—H functionalization, 
including catalyzing reactions with no biological counterparts. Enzymes could conceivably 
offer catalyst-controlled selectivity, high turnover numbers, or eliminate dependence on 
toxic noble metals, which are desirable advances for the field of C—H functionalization [1, 
2]. While protein engineering has historically focused on improving the known function of 
an enzyme [7], a recent paradigm shift has expanded this vision. The initial focus is now on 
the target reaction, such as a C—H functionalization transformation, and the necessary 
elements to achieve that chemistry, such as the ability to bind porphyrin. Protein engineers 
then search through the vast collection of existing proteins, select those which have the 
necessary parts (it can also be beneficial to introduce artificial cofactors or computationally 
design a suitable protein [8]), and test for the desired activity. Once even a low level of the 
activity has been found, a new enzyme can be created by directed evolution, a protein 
engineering strategy which uses iterative cycles of mutagenesis and screening to accumulate 
beneficial mutations that enhance catalyst performance (Figure 1b). This approach has 
generated porphyrin-containing enzymes which oxidize C—H bonds with tailored site-
selectivity and perform new-to-nature C—H amination and C—C bond forming reactions.
In this short opinion piece, we survey C—H functionalization transformations catalyzed by 
engineered heme proteins and the methods used to introduce or optimize these functions. 
These efforts are compelling precedents for expanding the chemistry accessible to proteins, 
and we anticipate that they will inform and inspire exploration of other protein systems for 
new catalytic functions.
Oxidative transformations catalyzed by engineered cytochromes P450
Cytochromes P450 are nature’s most prevalent catalysts for C—H functionalization [9]. 
Enzymes of this vast family directly activate inert C—H bonds for a broad spectrum of 
oxidative transformations such as hydroxylation, desaturation, decarboxylation, and carbon-
skeleton rearrangement [10, 11]. The exceptional activities of P450s have driven interest in 
utilizing them for diverse synthetic purposes [12]. With their remarkable capability for site-
selective catalysis, P450s can be useful for late-stage molecular diversification. The use of a 
directing group to effect site-selectivity, a concept commonly used in small-molecule 
catalysis, has been combined with P450-catalysis using PikC from Streptomyces venezuelae 
[13]. The natural substrates of PikC are macrolides, macrocyclic lactones with a desosamine 
sugar; the desosamine sugar acts as an anchoring group and the N,N-dimethylamino moiety 
forms a salt bridge with a protein glutamate residue [14]. From substrate engineering 
studies, it was found that various synthetic N,N-dimethylamino and N,N-diethylamino 
groups are also suitable anchoring groups and affect site-selectivity in PikC catalysis [15, 
16••]. In a powerful illustration of molecular diversification by enzymatic C–H 
functionalization, the merger of nickel and PikC catalysis accessed five different 
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hydroxylated macrocyclic lactone products from a common linear intermediate (Figure 2a) 
[16••]. In this reaction, nickel-catalyzed regiodivergent cyclization converted the linear 
intermediate into 11- and 12-membered macrocycles; after appending anchoring groups, a 
single enzyme variant acted on each substrate to hydroxylate at a different position with 
good regioselectivity. Complementary to a substrate engineering approach, the application of 
homologous P450s from different natural product pathways can also access diverse 
outcomes available to a molecule. Starting from one intermediate, a combination of 
polyketide synthase (PKS) modules, in vivo glycosylation, and three different P450s 
delivered several tylactonebased macrolide antibiotics with varied oxygenation patterns 
(Figure 2b) [17•].
P450s have also inspired new strategies for complex molecule synthesis by offering catalysts 
that address challenging selectivity issues [18]. A compelling example is the first 
enantioselective total synthesis of nigelladine A [19••]. In this synthesis, a site-selective 
allylic oxidation of a tricyclic intermediate at the C7 position is required. However, the 
presence of multiple reactive allylic C—H bonds in this intermediate significantly 
complicated the seemingly straightforward transformation. Indeed, a survey of a broad range 
of chemical oxidation methods only led to mixtures of inseparable mono-oxidation and over-
oxidation products. This synthetic challenge was solved by P450BM3 variant 8C7, which was 
identified through screening a small set of P450BM3 variants originally engineered for 
oxidation of large substrates with privileged scaffolds [20]. P450 8C7 efficiently catalyzed 
the desired C7 oxidation with up to 1700 total turnovers and enabled a concise synthesis of 
nigelladine A (Figure 2c).
Computational methods such as molecular dynamics (MD) simulations have emerged as 
powerful tools to facilitate the laboratory evolution/engineering of P450s [21]. These in 
silico methods can unveil key residues involved in important dynamic interactions that are 
not revealed by static structural data. Employing such a computation-driven approach, 
Narayan et al. expanded the scope of P450 PikC to include six-membered small ring systems 
[22•]. In another demonstration, by combining large-scale MD simulations with site-
saturation mutagenesis, Dodani et al. identified several mutations (His176Phe/Tyr/Trp) that 
completely redirect the regioselectivity of P450 TxtE-catalyzed nitration from the C4 to the 
C5 position of L-tryptophan [23•]. Additionally, there are also several studies that employ 
docking and MD simulation to identify important mutational hotspots for improving 
selectivity or substrate specificity of P450 hydroxylation [24, 25, 26].
Common to the many thousands of P450s is the conserved cysteine residue that acts as an 
axial ligand to the heme iron. This axial cysteine is crucial for the C—H activation activity 
of P450 compound I [27, 28]. In a study of the thermostable Sulfolobus acidocaldarius 
CYP119, mutation of the axial cysteine ligand to all other canonical amino acids created 
mutants which still folded and incorporated heme [29]. The crystal structure of a histidine-
ligated CYP119 variant exhibited a tilted heme accompanied by a large rearrangement of the 
protein structure. While mutation of the axial ligand typically results in diminished or 
abolished hydroxylation activity, Green et al. discovered that the hydroxylation activity of 
CYP119 compound I could be enhanced by mutation of the axial cysteine to selenocysteine 
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[30••]. This finding may open a new avenue for the development of robust P450 catalysts for 
additional challenging transformations.
Advancing biocatalytic C—H amination using directed evolution
The frequent presence of nitrogen in natural products and drug molecules drives the search 
for methods to form C—N bonds. Biological systems typically rely on enzymatic functional 
group manipulation of pre-oxidized substrates to forge this bond. This approach has been 
applied in the design of multi-enzyme biocatalytic cascades for formal C—H amination 
(Figure 3a) [31, 32]. As a complement to nature’s biosynthetic logic, recent work with 
engineered heme proteins has identified enzymes which directly install a C—N bond in 
place of an sp3-hydridized C—H bond.
In a study to produce metabolites of drug molecules, mutants of cytochrome P450BM3 were 
discovered to perform an unusual cyclization reaction on lidocaine (Figure 3b) [33]. The 
cyclization, an intramolecular C—H amination reaction, competes with N-dealkylation, a 
known reaction of P450s. The distribution of the two products is entirely controlled by the 
protein scaffold: two variants with divergent selectivity for N-dealkylation and cyclization 
differed by a single amino acid. Further work created a set of P450BM3 variants which 
performed α-functionalization of diverse 2-aminoacetamides and thioamides [34•]. In the 
proposed mechanism, P450 compound I is involved in the formation of an iminium species 
which subsequently undergoes cyclization. Examples of this transformation are limited to 
functionalization of α-amino C—H bonds, in agreement with the proposed mechanism. 
Wild-type P450BM3 did not catalyze the cyclization reaction or gave only low conversion 
(<5%) on model substrates, demonstrating that the discovered mutations promote the 
chemistry [34•].
Heme proteins are not limited to the reactions of iron-oxo intermediates. When given the 
opportunity to interact with certain nitrogen-containing substrates, heme proteins can 
putatively form iron-nitrene species, which can then perform C—H amination. Though first 
demonstrated nearly 35 years ago [35], it was only with the advent of modern directed 
evolution techniques that variants of P450BM3 adopted the C—H amination function with 
synthetically useful levels of activity [36, 37]. Remarkably, these enzymes can be engineered 
to alter the regioselectivity of amination in an intramolecular system and override substrate 
reactivity patterns [38]. The creation of an intramolecular C—H amination enzyme does not 
necessitate use of an enzyme scaffold: Physeter catodon myoglobin, which has no known 
natural catalytic function, was also engineered to perform this chemistry [39]. Additional 
testing of engineered heme proteins [40] and directed evolution of heme protein-derived 
catalysts, including a CYP119 derivative in which the heme group was replaced with Ir(Me)-
porphyrin [41], further expanded the scope of enzymatic C—H amination.
Intermolecular C—H amination affords increased synthetic flexibility. However, changing 
from an intramolecular to an intermolecular reaction is a fundamental challenge in catalysis 
[42], and to date there is only one report of heme protein-catalyzed intermolecular C—H 
amination [43••]. In the intermolecular reaction, C—H insertion must compete with iron-
nitrene decomposition pathways without the implicit proximity advantage of an 
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intramolecular arrangement. Nonetheless, directed evolution found a protein scaffold which 
overcame these challenges: a serine-ligated P450BM3 variant delivered seventeen different 
chiral amine compounds with good turnovers and high enantioselectivity (Figure 3c).
Previously thought to be absent from natural enzyme mechanisms, an iron-nitrene has been 
put forth as a possible intermediate for recently discovered cytochrome P450 BezE involved 
in benzastatin biosynthesis [44•]. This is an excellent demonstration of how findings from 
biocatalysis can inform mechanistic possibilities for enzymes in complex biosynthetic 
pathways. At the same time, the discovery of new enzymes provides biocatalysis with an 
increasing repertoire of starting points for the implementation of new chemistry.
Engineering heme proteins for C—C bond formation
A prevalent belief in biocatalysis is that proteins cannot access the diversity of chemical 
transformations available to synthetic chemistry. Some of this comes from the observation 
that biological systems appear to use just a small set of elements from the periodic table; for 
instance, known natural enzymes access their powerful and varied chemistry using 
predominantly earth-abundant first-row transition metals. In contrast, small-molecule 
catalysts for certain classes of reactions, such as sp3 C—H functionalization, commonly 
employ noble metals [1, 2].
The creation of artificial metalloenzymes which contain noble metal complexes [45, 46], 
including the replacement of the heme group in heme proteins with porphyrins containing 
alternative metals, is one strategy to expand the scope of reactions accessible to enzymes. 
Replacing the iron-porphyrin cofactor with an iridium-porphyrin creates artificial 
metalloenzymes which install a new C—C bond in place of an sp3 C—H bond (Figure 4a). 
First demonstrated using Physeter catodon myoglobin, protein variants containing the 
Ir(Me)-porphyrin complex and engineered by directed evolution catalyze enantioselective 
intramolecular carbene C—H insertion to deliver cyclic ether products [47••]. In agreement 
with previously observed reactivity patterns [6], the free Ir(Me)-porphyrin complex 
catalyzes the model reaction with a higher reaction rate than an Ir(Me)-porphyrin myoglobin 
enzyme. Changing the protein scaffold to apo-CYP119 and subsequent directed evolution, 
however, delivered an artificial metalloenzyme with 23-fold higher turnover frequency 
compared with the free cofactor [48•]. Intermolecular C—H functionalization of phthalan 
was accomplished using evolved variants of Ir(Me)-porphyrin CYP119 [48•] and variants of 
P. catodon apo-myoglobin equipped with porphyrins containing alternative metals, including 
iridium [49]. In contrast, the alkylation of sp2-hybridized C—H bonds of unprotected indole 
substrates has been achieved using variants of myoglobin which retain their native heme 
group. Chemoselective for C3 functionalization, the alkylation occurs through electrophilic 
aromatic substitution rather than a C—H insertion mechanism which is expected for sp3 C—
H functionalization [50•].
The described non-natural C—C bond-forming reactions proceed via the intermediacy of an 
electrophilic metal-carbene species. Remarkably, iron porphyrin carbene (IPC) intermediates 
in two engineered proteins have now been captured by X-ray crystallography and studied 
spectroscopically. Two recent reports show that the IPC can exist as either an end-on adduct 
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[51•], which is responsible for carbene transfer activity, or have a Fe–C–N(pyrrole) bridging 
configuration, which (if formed) is in equilibrium with the end-on adduct (Figure 4b) [52•]. 
These reports illustrate that the protein scaffold affects bonding and the electronic state of 
the IPC, and can even dictate the orientation of this intermediate [51•]. Together with 
knowledge gained from quantum chemical calculations on iron-porphyrin carbene systems 
[53, 54] and experimental work with small-molecule systems [55], these studies can inform 
new approaches to expand the limits of heme protein-catalyzed C—H functionalization.
Natural heme proteins have their own strategies to mediate C—H to C—C bond conversions 
[10]. Many of these transformations are catalyzed by cytochromes P450 and result from 
radical coupling (e.g. synthesis of salutaridine from reticuline in morphine biosynthesis [10], 
phenol coupling in fungal natural products [56]) or rearrangements of substrate radicals 
followed by quenching (e.g. transformation littorine to hyoscyamine aldehyde in tropane 
alkaloid biosynthesis [57]) (Figure 4c). The potentials of these enzymes for novel reactions 
have yet to be explored.
Outlook
New enzymes (some even with new cofactors [58]) are being discovered every day. 
Considering only cytochromes P450, there are more than 206,000 genes known in 2018 [10] 
vs. only 18,000 just five years ago [59]. The considerable diversity of heme proteins and 
their proven evolvability supply a fertile landscape for the discovery and optimization of new 
reactions. Although new-to-nature C—N and C—C bond-forming processes have not yet 
been applied in the context of complex molecule synthesis or diversification, the 
achievements of P450-catalyzed site-selective hydroxylation provide a roadmap. Looking 
forward, the successes of engineering heme proteins for diverse chemistry should stimulate 
experimentation with other groups of proteins for non-native catalysis [60]. Approaching 
nature’s protein diversity with a new chemical perspective and a powerful set of protein 
engineering tools, we see a bright future for creating new enzymes for selective C—H bond 
functionalization.
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Highlights
• Interplay between synthetic chemistry and enzyme discovery/creation.
• Cytochromes P450 for selective hydroxylation of complex molecules.
• Engineered heme proteins catalyze non-natural C—H functionalization 
reactions.
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Figure 1. 
Porphyrin is a versatile scaffold for C—H bond functionalization. (a) Porphyrin-based 
transition metal catalysts which functionalize C—H bonds. Examples are from ref. [4–6]. X, 
(1S,4R,5R,8S)-1,2,3,4,5,6,7,8-octahydro-1,4:5,8-dimethanoanthracene-9-yl. †Corresponding 
ketones were also formed; ketone formation is not due to further oxidation of alcohol 
products [4]. (b) Proteins which contain a porphyrin group have been engineered by directed 
evolution to perform C—H oxidation reactions with increased activity or tailored site-
selectivity, C—H amination, and carbene C—H insertion. Structural models are Bacillus 
megaterium cytochrome P450BM3 (PDB 1JPZ, top and middle) and an engineered C—H 
amination enzyme derived from P450BM3 (PDB 5UCW, bottom); Y, vinyl or ethyl; Z, amino 
acid or organic functional group.
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Figure 2. 
Cytochromes P450 catalyze diverse selective oxidative transformations. (a) Synthesis of 
macrocyclic lactones by merging nickel-catalyzed cyclization with P450-catalyzed C—H 
hydroxylation [16••]. (b) PKS catalysis followed by glycosylation and P450-catalyzed 
oxidation affords tylactone-based macrolides [17•]. (c) Site-selective oxidation by P450 8C7 
at the C7 position of an advanced intermediate in the total synthesis of nigelladine A [19••]. 
ADH, alcohol dehydrogenase; KPi, potassium phosphate; DMP, Dess–Martin periodinane.
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Figure 3. 
Representative examples of engineered heme proteins used for C—H amination. (a) 
Biocatalytic cascade for formal C—H amination [31]. (b) Cytochrome P450-catalyzed 
reactions of lidocaine [33]. Distribution between N-dealkylation and cyclization products is 
controlled by mutations to the protein scaffold. (c) Intermolecular C—H amination catalyzed 
by an engineered cytochrome P450 [43••]. This reaction proceeds through a putative iron-
nitrene intermediate. Four beneficial mutations, whose positions are shown as spheres in the 
structural model (PDB 5UCW), were accumulated in the directed evolution of a C—H 
amination enzyme. †The initial protein was an engineered variant of P450BM3 which differs 
from wild-type by seventeen mutations.
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Figure 4. 
C—H to C—C bond transformations catalyzed by artificial metalloenzymes and 
cytochromes P450. (a) Replacement of heme in myoglobin with Ir(Me)-mesoporphyrin IX 
results in an artificial metalloenzyme which catalyzes carbene C—H insertion, a reaction 
that the iron-based enzyme does not catalyze [47••]. Cartoons were created using PDB 
1MBN; porphyrin cofactors have been enlarged (not to scale). (b) The IPC intermediate has 
been captured by X-ray crystallography in two poses, end-on (left, PDB 6CUN) and Fe–C– 
N(pyrrole) bridging (right, PDB 6G5B), in engineered cytochrome c and myoglobin carbene 
transferases, respectively [51•, 52•]. (c) P450 catalyzed C—C bond forming reactions in 
natural product biosynthesis. Representative examples are from ref. [10], [56], and [57] (left 
to right).
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